SEC Form D · filed August 9, 2016
Frontida Biopharm, Inc
Offering
$10.0M
Sold
$8.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
EXTON, PA
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (2)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗